Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Cancer Health Equity Research
- 1st Edition, Volume 146 - March 30, 2020
- Editors: Marvella E. Ford, Judith Salley, Nestor Esnaola
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 0 1 7 6 - 3
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 0 1 7 7 - 0
Cancer Health Equity Research, Volume 146 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chap… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteCancer Health Equity Research, Volume 146 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Pubertal Mammary Development as a ‘Susceptibility Window’ for Breast Cancer Disparity, Review of Patient Navigation Interventions to Address Barriers to Participation in Cancer Clinical Trials, Racial Disparities in Ovarian Cancer Research, Mighty Men: A Faith-Based Weight Loss Intervention to Reduce Cancer Risk in African American Men, Design of a Patient Navigation Intervention to Increase Rates of Surgery among African Americans with Early-Stage Lung Cancer, and much.
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in the Advances in Cancer Research series
- Updated release includes the latest information on the Cancer Health Equity Research
Scientists, clinicians, and students at all levels
1. Pubertal Mammary Development as a ‘Susceptibility Window’ for Breast Cancer Disparity
2. Review of Patient Navigation Interventions to Address Barriers to Participation in Cancer Clinical Trials
3. Racial Disparities in Ovarian Cancer Research
4. Mighty Men: A Faith-Based Weight Loss Intervention to Reduce Cancer Risk in African American men
5. Design of a Patient Navigation Intervention to Increase Rates of Surgery among African Americans with Early-Stage Lung Cancer
6. ACR Age-Related Disparities in Older Women with BC
7. A Primer for Cancer Research Programs on Defining and Evaluating the Catchment Area and Evaluating Minority Clinical Trials Recruitment
8. Assessing an Intervention to Increase Cervical Cancer Knowledge and HPV Vaccination Intention in SC
9. Project PLACE: Population level approaches to cancer elimination leveraging community partnerships to describe and address cancer disparities
10. Race and Mobility Limitation among Prostate Cancer Survivors
- No. of pages: 246
- Language: English
- Edition: 1
- Volume: 146
- Published: March 30, 2020
- Imprint: Academic Press
- Hardback ISBN: 9780128201763
- eBook ISBN: 9780128201770
MF
Marvella E. Ford
Dr. Marvella E. Ford is a tenured Professor in the Department of Public Health Sciences at the Medical University of South Carolina (MUSC) College of Medicine. Dr. Ford is the Associate Director of Population Sciences and Cancer Disparities at the National Institutes of Health/National Cancer Institute (NIH/NCI)-designated MUSC Hollings Cancer Center. She also serves as the SmartState Endowed Chair in Cancer Disparities, Prostate Cancer Disparities Center of Economic Excellence at South Carolina State University (SCSU). Dr. Ford received her master of science in social psychology, master of social work in policy and planning, and doctor of philosophy degree in social work and psychology from the University of Michigan, where she also completed a postdoctoral fellowship in health and aging. Dr. Ford’s research interests include cancer disparities, gerontology, and recruitment and retention of diverse populations in clinical trials.
Dr. Ford has served as principal investigator for a number of federally-funded research grants focused on cancer disparities. In collaboration with Dr. Judith Salley from SCSU, Dr. Ford led an NIH/NCI U54 grant with the goal of expanding cancer disparities research in South Carolina while cultivating a diverse network of cancer researchers titled, “South Carolina Cancer Disparities Research Center (SC CADRE)”. This grant provided support for cancer disparities research at MUSC and SCSU, and provided opportunities for underrepresented students and junior faculty to gain training in cancer research methods.
In her role as a multiple principal investigator Dr. Ford has led an NIH/NCI-funded Minority Based Community Oncology Research Program together with Drs. Chanita Hughes-Halbert, Carolyn Britten, and David Marshall to increase the participation of diverse participants in cancer research. Dr. Ford has also collaborated with Dr. Nestor Esnaola as a multiple principal investigator of an NIH/National Institute on Minority Health and Health Disparities grant titled “Improving Resection Rates among African Americans with NSCLC.” The study’s goal was to evaluate a strategy to improve rates of receipt of surgery among African Americans with early-stage lung cancer.
Dr. Ford has also led several cancer research training programs funded by the NIH/NCI and Department of Defense in collaboration with the University of South Carolina and three historically black colleges/universities (HBCUs) in South Carolina: Claflin University, South Carolina State University, and Voorhees College. To date, Dr. Ford has published more than 95 peer-reviewed scientific papers, many written in collaboration with HBCU undergraduate students, as well as nine book chapters.
Affiliations and expertise
Department of Public Health Sciences and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USAJS
Judith Salley
Dr. Judith Salley is a tenured professor of biology and serves as the chairperson of the Department of Biological and Physical Sciences at South Carolina State University (SCSU). She received a Bachelor of Science degree in biology from SC State University and both a Master’s and PhD degree in Zoology from the Ohio State University in Columbus, Ohio.
Dr. Salley, in collaboration with Dr. Marvella Ford from the Medical University of South Carolina, has been instrumental in building strong and enduring partnerships with colleges and universities in the state of South Carolina especially HBCUs, to develop several research and education training programs in cancer disparities for underrepresented students and junior faculty. Drs. Salley and Ford successfully initiate an inter-institutional, P20 CPACHE Planning Center grant, funded by the National Institutes of Health (NIH/NCI) titled South Carolina Cancer Disparities Research Center (SC CaDRe), which led to a funded U54 grant tilted “South Carolina Cancer Disparities Research Center (SC CADRE).” The Center was established to build research capacity and infrastructure at SCSU and to expand cancer disparities research in the state of South Carolina while cultivating a diverse network of cancer researchers. In addition, Dr. Salley serves as a Multiple PI with Dr. Marvella Ford on the SmartState Center of Economic Excellence in Prostate Cancer Disparities Research. The Center is designed to develop and test interventions to significantly enhance the participation of African American men in prostate cancer screening and early detection. She is also the principal investigator of the NIH IDeA Network of Biomedical Research Excellence (INBRE) Program at South Carolina State University. INBRE’s goal is to increase biomedical research opportunities and training for faculty and minority undergraduates. Dr. Salley has also served as the principal investigator of the NSF funded SC Experimental Program to Stimulate Competitive Research (SC EPSCoR), a grant designed to develop a Master’s degree in Bioengineering Sciences at SC State and to address the shortage of underrepresented minorities who pursue the Ph.D. in bioengineering and related fields.
Affiliations and expertise
Chairperson of the Department of Biological and Physical Sciences at South Carolina State University (SCSU)NE
Nestor Esnaola
Dr. Esnaola is Division Chief of Surgical Oncology and Gastrointestinal Surgery in the Department of Surgery at Houston Methodist Hospital and Surgical Director of the Houston Methodist Cancer Center. He is an experienced, clinically active surgical oncologist and participates in the multidisciplinary care of complex patients with gastrointestinal cancers (including primary and metastatic colorectal cancer), hepatico-pancreatico-biliary malignancies, and soft tissue sarcomas.
He is a graduate of Rice University and the Johns Hopkins University School of Medicine. He completed a residency in general surgery at Brigham and Women’s Hospital/ Harvard Medical School and subsequently completed clinical/research fellowships in surgical oncology at the University of Texas M. D. Anderson Cancer Center.
Dr. Esnaola completed a Master in Public Health at the Harvard School of Public Health. His research interests include clinical and translational cancer health disparities research, decision and cost-effectiveness analysis, dissemination and implementation research, process of care and cancer care delivery trials, and novel neoadjuvant therapies for solid tumors. Previous collaborations with Dr. Marvella Ford have addressed racial/ethnic differences and disparities in cancer care and outcomes. Their work has identified risk factors for underuse of attempted curative resection in patients with non-metastatic breast, lung, and colorectal cancer and provided an evidence base to guide future interventions to optimize cancer care and narrow the persistent gap in cancer outcomes among underserved populations.
As a graduate of the American Association for Cancer Research Integrative Molecular Epidemiology Workshop, the American Association for Cancer Research /American Society of Clinical Oncology Methods in Clinical Cancer Research Workshop, the Southwest Oncology Group Young Investigators Training Course, and the American College of Surgeons Clinical Trials Methods Course, he is well-versed and experienced in the design/conduct of translational research, as well as phase I-III clinical trials. He currently serves as Multi-PI (with Dr. Marvella Ford) on a National Center on Minority Health and Health Disparities RO1-funded, National Cancer Institute Community Oncology Research Program-sponsored, multi-state, cluster-randomized clinical trial to increase rates of lung-directed therapy with curative intent in African Americans with early stage lung cancer. As Associate Director for Cancer Control and Population Sciences at the Houston Methodist Cancer Center, he is tasked with optimizing ongoing community outreach and engagement initiatives and ensuring that the Center’s clinical and research enterprise addresses the cancer burden and needs of its catchment area.
Dr. Esnaola also completed a Master in Business Administration at the Haslam College of Business /University of Tennessee and has a long-standing interest in optimizing perioperative processes of care to maximize surgical quality (including equity), safety, and value. As Leader of the Best Practices Initiative for American College of Surgeons National Surgical Quality Improvement Program, he developed several evidence-based, expert panel-rated Best Practice Guidelines designed to preventing common postoperative complications and enhance perioperative care of geriatric surgical patients.
Dr.Esnaola is a Fellow of the American College of Surgeons, and an active member of the Society of Surgical Oncology, the American Society of Clinical Oncology, the American Association of Cancer Research, the Association for Academic Surgery, and the Society of University Surgeons. He is also a consultant for the American Board of Surgery General Surgery and Complex General Surgical Oncology Qualifying Examinations, and examiner for their respective Certifying Examinations. He has served on/led multiple National Institute of Health and National Cancer Institute study sections, and is a standing member of the Agency for Health Care Research and Quality’s Health Care Effectiveness and Outcomes Research Study Section.
Affiliations and expertise
Division Chief of Surgical Oncology and Gastrointestinal Surgery in the Department of Surgery at Houston Methodist Hospital and Surgical Director of the Houston Methodist Cancer Center